Global Paediatric Vaccine market (2020-2025) by Type, Technology, Application, Geography and the Impact of Covid-19 with Ansoff Analysis

Early vaccination helps to develop antibodies against several infectious diseases. Vaccinations are prescribed in different age groups. Early immunization can prevent 2 million to 3 million deaths every year. Vaccine-preventable diseases are known to have a costly impact leading to frequent hospitalizations and death in certain cases. As per the UNICEF, an estimated 14 million infants have not received the vaccination, and around 85 countries are still to receive the Global Vaccination Action Plan (GVAP).

Pediatric vaccines are administered to an infant in its pediatric stage i.e. (0-12). These vaccines include the DTP vaccine, MMR vaccine, polio vaccine, and meningococcal vaccine, etc. They are usually administered at regular intervals to fight against infections and seasonal variations. In today's dynamic business environment, there has been an excessive focus on R&D for the vaccines and the maximum coverage of the infant vaccines. With the increasing focus of the Government on vaccination, pediatric vaccines have increased over time. Besides, technologies such as synthetic vaccinology and platform manufacturing can help speed up the processing time taken to manufacture the new vaccines. This can additionally also help in improving the vaccination rate. Healthcare associations like the UNICEF or the WHO actively promote immunization campaigns, especially in developing countries.

The Global Pediatric Vaccines Market is estimated to be USD 45 Bn in 2020 and is expected to reach USD 74.5 Bn by 2025, growing at a CAGR of 10.6%.



Certain factors, such as the rising number of chronic diseases across the globe along with the global initiatives taken towards vaccine production for rare diseases, have been major drivers of growth for the pediatric market. Increasing cases of invasive cervical cancer are also expected to fuel the growth of the market. Such cancer types can be prevented through the HPV vaccine and regular cervical screenings between the ages of 9-12. Additionally, increasing awareness about the importance of pediatric vaccination in the prevention of diseases is expected to fuel market growth.

However, the costs attached to immunization and the accessibility restrains the growth of this market. The increasing availability of biosimilar at low rates is also creating hindrances for the market.

Market Dynamics

Drivers

• Rising Burden of Chronic Diseases
• Technological Advancements in Vaccines
• Favorable Government Support in Promoting Vaccination

Restraints

• Cost of Immunization
• Low Medical Coverage and Healthcare Services in Low- and Middle-income Countries

Opportunities

• Growing Importance and Awareness of Immunization
• Rising Number of Collaborations, Expansions, and Mergers

Challenges

• Stringent Regulatory Compliance in the Development of Vaccines
• Refusal of Immunization due to Low Awareness and Vaccines Shortages

Trends

• The Emergence of a Paediatric Vaccine as a Therapeutic Agent Against Cervical Cancer

Segments Covered

By Vaccine Type, the Monovalent Vaccine is estimated to account for the fastest-growing segment during the forecast period. It has been noted that many of the newly approved pediatric vaccines, as well as existing pediatric vaccines today, are monovalent vaccines, thus adding to the market growth.

By Technology, Conjugate/Subunit Vaccines are estimated to be the fastest-growing segment during the forecast period. It is due to the high immune response provided to the body by the vaccine to fight against specific types of microorganisms. Thus, the rising number of regulatory approvals for conjugate vaccines have been major promoters of growth.

By Application, The Infectious Diseases Segment holds the largest share due to rising global awareness about immunization against infectious diseases that cause death. An increase in the incidence of diseases, such as chickenpox, typhoid, cholera, measles, and hepatitis, in infants, results in high demand for immunization, which positively impacts the market.

By Geography, North America is anticipated to lead the market. The factors attributed to the growth of the market are the growing incidences of infectious diseases, availability of reimbursement schemes, new product approvals, and high spending and initiatives taken by the Government in the healthcare industry. The European market is also expected to grow due to the ease of operability, efficient resource planning, a large number of pharmaceutical manufacturers, and rising government funding.

The Global Paediatric Vaccine market is further segmented on the basis of Type, Technology, Application, and Geography.

Global Paediatric Vaccines Market, By Vaccine Type

• Introduction
• Monovalent
• Multivalent

Global Paediatric Vaccines Market, By Technology

• Introduction
• Live Attenuated
• Inactivated
• Subunits
• Toxoid
• Conjugate
• Other Technologies

Global Paediatric Vaccines Market, By Application

• Introduction
• Infectious Diseases
• Cancer
• Allergies
• Other Applications

Global Paediatric Vaccines Market, By Geography

• Introduction
• North America
• South America
• Europe
• Asia Pacific
• The Middle East and Africa

Company Profiles

Some of the companies covered in this report are Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Grifols, Serum Institute of India Pvt. Ltd., AstraZeneca, Cadila Healthcare Ltd, Indian Immunologicals Limited, and CSL Limited.

IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

• Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
• Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
• Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market
• Tortoise: Companies which are slow in growth, having a long legacy, and stable or negative in performance

Why buy this report?

• The report offers a comprehensive evaluation of the Global Paediatric Vaccines Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of COVID-19 on the market is also featured in the report.
• The report also contains the competitive analysis using IGR Positioning Quadrants, the analyst's proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market